These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9604243)

  • 21. Transvenous single lead atrial defibrillation: efficacy and risk of ventricular fibrillation in an ischemic canine model.
    Osswald S; Trouton TG; Roelke M; O'Nunain SS; Fallon JT; Holden HB; Ruskin JN; Garan H
    Pacing Clin Electrophysiol; 1998 Mar; 21(3):580-9. PubMed ID: 9558691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-atrial defibrillation of human atrial fibrillation.
    Santini M; Pandozi C; Gentilucci G; Villani M; Scianaro MC
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S170-6. PubMed ID: 9727694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transvenous internal cardioversion for atrial fibrillation: a randomized comparison between catheters with different coil length.
    Boriani G; Biffi M; Camanini C; Sammali A; Bacchi L; Accorti P; Luceri R; Zannoli R; Branzi A
    Am Heart J; 2002 Nov; 144(5):851-7. PubMed ID: 12422155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
    Lai LP; Lin JL; Lien WP; Tseng YZ; Huang SK
    J Am Coll Cardiol; 2000 May; 35(6):1434-41. PubMed ID: 10807444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of electrode position on outcome of low-energy intracardiac cardioversion of atrial fibrillation.
    Alt E; Schmitt C; Ammer R; Plewan A; Evans F; Pasquantonio J; Ideker T; Lehmann G; Pütter K; Schömig A
    Am J Cardiol; 1997 Mar; 79(5):621-5. PubMed ID: 9068520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Internal low energy atrial cardioversion: efficacy and safety in older patients with chronic persistent atrial fibrillation.
    Boriani G; Biffi M; Magagnoli G; Zannoli R; Branzi A
    J Am Geriatr Soc; 2001 Jan; 49(1):80-4. PubMed ID: 11207847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internal atrial defibrillation: effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers.
    Prakash A; Saksena S; Mathew P; Krol RB
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 1):2434-41. PubMed ID: 9358485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation sequences following failed atrial defibrillation.
    Zheng X; Huang J; Walcott GP; Smith WM; Ideker RE
    Heart Rhythm; 2004 Nov; 1(5):616-23. PubMed ID: 15851229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.
    Murgatroyd FD; Slade AK; Sopher SM; Rowland E; Ward DE; Camm AJ
    J Am Coll Cardiol; 1995 May; 25(6):1347-53. PubMed ID: 7722132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation.
    Villani GQ; Piepoli MF; Capucci A
    Europace; 2004 Jul; 6(4):267-72. PubMed ID: 15172649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of biphasic waveform tilt in transvenous atrial defibrillation.
    Sra J; Bremner S; Krum D; Dhala A; Blanck Z; Deshpande S; Biehl M; Li H; Jazayeri MR; Akhtar M
    Pacing Clin Electrophysiol; 1997 Jun; 20(6):1613-8. PubMed ID: 9227757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internal cardioversion of atrial fibrillation in sheep.
    Cooper RA; Alferness CA; Smith WM; Ideker RE
    Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Internal cardioversion of chronic atrial fibrillation in patients.
    Neri R; Palermo P; Cesario AS; Baragli D; Amici E; Gambelli G
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2237-42. PubMed ID: 9309749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial clinical experience with an implantable human atrial defibrillator.
    Lau CP; Tse HF; Lok NS; Lee KL; Ho DS; Sopher M; Murgatroyd F; Camm AJ
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):220-5. PubMed ID: 9121994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left atrial mechanical function after brief duration atrial fibrillation.
    Sparks PB; Jayaprakash S; Mond HG; Vohra JK; Grigg LE; Kalman JM
    J Am Coll Cardiol; 1999 Feb; 33(2):342-9. PubMed ID: 9973013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
    Boriani G; Biffi M; Capucci A; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Magnani B
    J Am Coll Cardiol; 1999 Feb; 33(2):333-41. PubMed ID: 9973012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
    Heisel A; Jung J; Fries R; Stopp M; Sen S; Schieffer H; Ozbek C
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):65-71. PubMed ID: 9121973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation.
    Sra JS; Maglio C; Dhala A; Blanck Z; Biehl M; Deshpande S; Keelan ET; Jazayeri MR; Akhtar M
    J Am Coll Cardiol; 1996 Nov; 28(6):1532-8. PubMed ID: 8917268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations.
    Saksena S; Prakash A; Mangeon L; Varanasi S; Kolettis T; Mathew P; De Groot P; Mehra R; Krol RB
    Am J Cardiol; 1995 Nov; 76(12):913-21. PubMed ID: 7484831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.
    Tse HF; Lau CP; Ayers GM
    Heart; 1999 Sep; 82(3):319-24. PubMed ID: 10455082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.